New cancer clinical trial: A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer

Published on: February 16, 2018 at 12:00PM
Conditions:   Pancreatic Cancer;   Metastatic Pancreatic Cancer
Intervention:   Drug: CPI 613 in Combination With Gemcitabine and Nab-paclitaxel
Sponsors:   Atlantic Health System;   Rafael Pharmaceuticals, Inc
Recruiting
http://ift.tt/2HuIGy9